Trial Profile

A Phase 3 Study Comparing Once Daily Treatment With Calcipotriol 50 Mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension With Betamethasone 0.5 mg/g (as Dipropionate) in the Topical Suspension Vehicle, Calcipotriol 50mcg/g in the Topical Suspension Vehicle and the Topical Suspension Vehicle Alone in Subjects With Psoriasis Vulgaris on Non-scalp Regions of the Body (Trunk and/or Limbs).

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone dipropionate; Calcipotriol
Indications Plaque psoriasis
Focus Registrational; Therapeutic Use
Sponsors LEO Pharma

12 Aug 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
12 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
16 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com